Pieter Cullis, NTx co-founder and Board Chair, takes the centre stage at the Delivery of Nucleic Acid Therapeutics Meeting (Keystone Symposia) in Banff, Alberta, Canada, January 22-25.

Pieter’s talk, “A Career of Lipid Nanoparticle Development Leading to the Commercial Success of RNA Therapies,” promises insights into groundbreaking discoveries leading to translation from bench to bedside.